Cargando…
Cytokine Levels Correlate with Immune Cell Infiltration after Anti-VEGF Therapy in Preclinical Mouse Models of Breast Cancer
The effect of blocking VEGF activity in solid tumors extends beyond inhibition of angiogenesis. However, no studies have compared the effectiveness of mechanistically different anti-VEGF inhibitors with respect to changes in tumor growth and alterations in the tumor microenvironment. In this study w...
Autores principales: | Roland, Christina L., Lynn, Kristi D., Toombs, Jason E., Dineen, Sean P., Udugamasooriya, D. Gomika, Brekken, Rolf A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2766251/ https://www.ncbi.nlm.nih.gov/pubmed/19888452 http://dx.doi.org/10.1371/journal.pone.0007669 |
Ejemplares similares
-
Identification of lipid-phosphatidylserine (PS) as the target of unbiasedly selected cancer specific peptide-peptoid hybrid PPS1
por: Desai, Tanvi J., et al.
Publicado: (2016) -
GU81, a VEGFR2 antagonist peptoid, enhances the anti-tumor activity of doxorubicin in the murine MMTV-PyMT transgenic model of breast cancer
por: Lynn, Kristi D, et al.
Publicado: (2010) -
VEGF and Pleiotrophin Modulate the Immune Profile of Breast Cancer
por: Lynn, Kristi D., et al.
Publicado: (2010) -
Development of a large peptoid–DOTA combinatorial library
por: Singh, Jaspal, et al.
Publicado: (2016) -
r84, a Novel Therapeutic Antibody against Mouse and Human VEGF with Potent Anti-Tumor Activity and Limited Toxicity Induction
por: Sullivan, Laura A., et al.
Publicado: (2010)